637 related articles for article (PubMed ID: 28888912)
1. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.
Bandari SK; Purushothaman A; Ramani VC; Brinkley GJ; Chandrashekar DS; Varambally S; Mobley JA; Zhang Y; Brown EE; Vlodavsky I; Sanderson RD
Matrix Biol; 2018 Jan; 65():104-118. PubMed ID: 28888912
[TBL] [Abstract][Full Text] [Related]
2. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes.
Thompson CA; Purushothaman A; Ramani VC; Vlodavsky I; Sanderson RD
J Biol Chem; 2013 Apr; 288(14):10093-10099. PubMed ID: 23430739
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.
Ramani VC; Vlodavsky I; Ng M; Zhang Y; Barbieri P; Noseda A; Sanderson RD
Matrix Biol; 2016 Sep; 55():22-34. PubMed ID: 27016342
[TBL] [Abstract][Full Text] [Related]
4. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
5. Heparanase promotes myeloma stemness and in vivo tumorigenesis.
Tripathi K; Ramani VC; Bandari SK; Amin R; Brown EE; Ritchie JP; Stewart MD; Sanderson RD
Matrix Biol; 2020 Jun; 88():53-68. PubMed ID: 31812535
[TBL] [Abstract][Full Text] [Related]
6. Heparanase activates the syndecan-syntenin-ALIX exosome pathway.
Roucourt B; Meeussen S; Bao J; Zimmermann P; David G
Cell Res; 2015 Apr; 25(4):412-28. PubMed ID: 25732677
[TBL] [Abstract][Full Text] [Related]
7. Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.
Ramani VC; Zhan F; He J; Barbieri P; Noseda A; Tricot G; Sanderson RD
Oncotarget; 2016 Jan; 7(2):1598-607. PubMed ID: 26624982
[TBL] [Abstract][Full Text] [Related]
8. Heparanase: A Dynamic Promoter of Myeloma Progression.
Purushothaman A; Sanderson RD
Adv Exp Med Biol; 2020; 1221():331-349. PubMed ID: 32274716
[TBL] [Abstract][Full Text] [Related]
9. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.
Purushothaman A; Uyama T; Kobayashi F; Yamada S; Sugahara K; Rapraeger AC; Sanderson RD
Blood; 2010 Mar; 115(12):2449-57. PubMed ID: 20097882
[TBL] [Abstract][Full Text] [Related]
10. Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.
Purushothaman A; Chen L; Yang Y; Sanderson RD
J Biol Chem; 2008 Nov; 283(47):32628-36. PubMed ID: 18812315
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions.
Purushothaman A; Bandari SK; Liu J; Mobley JA; Brown EE; Sanderson RD
J Biol Chem; 2016 Jan; 291(4):1652-1663. PubMed ID: 26601950
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles released during hypoxia transport heparanase and enhance macrophage migration, endothelial tube formation and cancer cell stemness.
Tripathi K; Bandari SK; Sanderson RD
Proteoglycan Res; 2023 Jan; 1(1):. PubMed ID: 37091070
[TBL] [Abstract][Full Text] [Related]
13. Heparanase Involvement in Exosome Formation.
David G; Zimmermann P
Adv Exp Med Biol; 2020; 1221():285-307. PubMed ID: 32274714
[TBL] [Abstract][Full Text] [Related]
14. Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity.
Ramani VC; Yang Y; Ren Y; Nan L; Sanderson RD
J Biol Chem; 2011 Feb; 286(8):6490-9. PubMed ID: 21131364
[TBL] [Abstract][Full Text] [Related]
15. SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.
Ritchie JP; Ramani VC; Ren Y; Naggi A; Torri G; Casu B; Penco S; Pisano C; Carminati P; Tortoreto M; Zunino F; Vlodavsky I; Sanderson RD; Yang Y
Clin Cancer Res; 2011 Mar; 17(6):1382-93. PubMed ID: 21257720
[TBL] [Abstract][Full Text] [Related]
16. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.
Yang Y; Macleod V; Miao HQ; Theus A; Zhan F; Shaughnessy JD; Sawyer J; Li JP; Zcharia E; Vlodavsky I; Sanderson RD
J Biol Chem; 2007 May; 282(18):13326-33. PubMed ID: 17347152
[TBL] [Abstract][Full Text] [Related]
17. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.
Sanderson RD; Elkin M; Rapraeger AC; Ilan N; Vlodavsky I
FEBS J; 2017 Jan; 284(1):42-55. PubMed ID: 27758044
[TBL] [Abstract][Full Text] [Related]
18. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma.
Si J; Li W; Li X; Cao L; Chen Z; Jiang Z
Cancer Sci; 2021 Sep; 112(9):3491-3506. PubMed ID: 34036683
[TBL] [Abstract][Full Text] [Related]
19. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts.
Faict S; Muller J; De Veirman K; De Bruyne E; Maes K; Vrancken L; Heusschen R; De Raeve H; Schots R; Vanderkerken K; Caers J; Menu E
Blood Cancer J; 2018 Nov; 8(11):105. PubMed ID: 30409995
[TBL] [Abstract][Full Text] [Related]
20. Heparanase: busy at the cell surface.
Fux L; Ilan N; Sanderson RD; Vlodavsky I
Trends Biochem Sci; 2009 Oct; 34(10):511-9. PubMed ID: 19733083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
